Zhiling Li
Impact in
- Genetics top 5%
- Mesenchymal stem cell research
- Reproductive Medicine top 10%
- Sperm and Testicular Function
Papers in
-
- Pluripotent Stem Cells Research 3
- Ubiquitin and proteasome pathways 2
-
- Reproductive Biology and Fertility 10
- Co-authors
- Puchang Lie (1 shared paper)Xing Wei (1 shared paper)Mingyan Chen (1 shared paper)Yue Huang (8 shared papers)Wanfen Xiao (10 shared papers)Man Chen (6 shared papers)Shuguang Ma (1 shared paper)Swapan Kumar Chowdhury (1 shared paper)
- Journals
- Frontiers in Pharmacology (4 papers)Stem Cell Research & Therapy (2 papers)Molecular Medicine (2 papers)Frontiers in Cell and Developmental Biology (2 papers)Expert Opinion on Drug Safety (2 papers)
- Partner nations
- ChinaUnited StatesPakistan
In The Last Decade
Zhiling Li
56 papers receiving 961 citations
Peers
Comparison fields: 5 of 106
- Genetics 176
- Reproductive Medicine 64
- Molecular Biology 379
- Molecular Medicine 26
- Public Health, Environmental and Occupational Health 131
Countries citing papers authored by Zhiling Li
This map shows the geographic impact of Zhiling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiling Li more than expected).
Fields of papers citing papers by Zhiling Li
This network shows the impact of papers produced by Zhiling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiling Li. The network helps show where Zhiling Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhiling Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 226 | |
| 2 | 2010 | 45 | |
| 3 | 2016 | 38 | |
| 4 | 2016 | 36 | |
| 5 | 2021 | 36 | |
| 6 | 2016 | 34 | |
| 7 | 2019 | 33 | |
| 8 | 2022 | 32 | |
| 9 | 2023 | 29 | |
| 10 | 2012 | 28 | |
| 11 | 116 cases of neonatal early-onset or late-onset sepsis: A single center retrospective analysis on pathogenic bacteria species distribution and antimicrobial susceptibility. | 2013 | 27 |
| 12 | 2013 | 26 | |
| 13 | 2020 | 24 | |
| 14 | 2022 | 22 | |
| 15 | 2021 | 22 | |
| 16 | 2021 | 21 | |
| 17 | 2020 | 21 | |
| 18 | 2023 | 19 | |
| 19 | 2014 | 17 | |
| 20 | 1996 | 17 |
About Zhiling Li
Zhiling Li is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health, Reproductive Medicine, Immunology and Plant Science, having authored 60 papers that have together received 988 indexed citations. Recurring topics across this work include Reproductive Biology and Fertility (10 papers), Sperm and Testicular Function (7 papers), Microtubule and mitosis dynamics (4 papers), Pluripotent Stem Cells Research (3 papers), Ubiquitin and proteasome pathways (2 papers), Osteoarthritis Treatment and Mechanisms (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). The work is most often cited by research in Genetics (176 citations), Reproductive Medicine (64 citations), Molecular Biology (379 citations), Molecular Medicine (26 citations) and Public Health, Environmental and Occupational Health (131 citations). Zhiling Li has collaborated with scholars based in China, United States and Pakistan. Frequent co-authors include Puchang Lie, Xing Wei, Mingyan Chen, Yue Huang, Wanfen Xiao, Man Chen, Shuguang Ma, Swapan Kumar Chowdhury, Xuefei Xiao and Pei He. Their work appears in journals such as Frontiers in Pharmacology, Stem Cell Research & Therapy, Molecular Medicine, Frontiers in Cell and Developmental Biology and Expert Opinion on Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.